CAROZZI, VALENTINA ALDA
 Distribuzione geografica
Continente #
NA - Nord America 18.310
AS - Asia 13.252
EU - Europa 8.719
SA - Sud America 1.519
AF - Africa 258
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 25
Totale 42.136
Nazione #
US - Stati Uniti d'America 17.243
SG - Singapore 4.413
CN - Cina 2.953
VN - Vietnam 2.435
IT - Italia 1.783
HK - Hong Kong 1.490
DE - Germania 1.315
RU - Federazione Russa 1.311
BR - Brasile 1.165
SE - Svezia 973
CA - Canada 904
IE - Irlanda 815
UA - Ucraina 643
GB - Regno Unito 526
FR - Francia 365
IN - India 351
KR - Corea 265
FI - Finlandia 243
BD - Bangladesh 209
ID - Indonesia 190
AT - Austria 153
JP - Giappone 149
TR - Turchia 145
AR - Argentina 138
IQ - Iraq 119
NL - Olanda 112
MX - Messico 102
ZA - Sudafrica 91
ES - Italia 90
PK - Pakistan 77
DK - Danimarca 72
PL - Polonia 71
SA - Arabia Saudita 63
LT - Lituania 58
PH - Filippine 57
CH - Svizzera 55
MY - Malesia 50
EC - Ecuador 45
CO - Colombia 43
BE - Belgio 42
IR - Iran 37
VE - Venezuela 37
UZ - Uzbekistan 36
AU - Australia 35
MA - Marocco 30
CL - Cile 28
EG - Egitto 28
PY - Paraguay 28
AE - Emirati Arabi Uniti 27
TN - Tunisia 24
KE - Kenya 21
TW - Taiwan 20
ET - Etiopia 19
EU - Europa 19
NP - Nepal 19
JO - Giordania 18
OM - Oman 17
TH - Thailandia 17
AZ - Azerbaigian 16
NZ - Nuova Zelanda 16
RO - Romania 14
IL - Israele 12
BO - Bolivia 11
KZ - Kazakistan 11
PE - Perù 11
UY - Uruguay 11
HN - Honduras 10
JM - Giamaica 10
PS - Palestinian Territory 10
CZ - Repubblica Ceca 9
DZ - Algeria 9
NI - Nicaragua 9
CR - Costa Rica 8
LB - Libano 8
TT - Trinidad e Tobago 8
AL - Albania 7
NG - Nigeria 7
BG - Bulgaria 6
BH - Bahrain 6
HU - Ungheria 6
PT - Portogallo 6
RS - Serbia 6
AO - Angola 5
CI - Costa d'Avorio 5
KG - Kirghizistan 5
LV - Lettonia 5
MD - Moldavia 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
GE - Georgia 4
GR - Grecia 4
HR - Croazia 4
KW - Kuwait 4
PA - Panama 4
SN - Senegal 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
PR - Porto Rico 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 42.087
Città #
Singapore 2.690
Ann Arbor 2.214
Hong Kong 1.438
Ashburn 1.402
San Jose 1.197
Dallas 1.196
Woodbridge 901
Dublin 781
Ho Chi Minh City 729
Chandler 714
Houston 682
Frankfurt am Main 664
Toronto 645
Milan 638
Jacksonville 623
Hanoi 545
Fairfield 535
Dearborn 505
Wilmington 490
New York 464
Santa Clara 388
Beijing 380
Los Angeles 354
Hangzhou 344
Princeton 304
Chicago 280
The Dalles 267
Council Bluffs 245
Boardman 237
Seattle 235
Seoul 222
Hefei 220
Nanjing 203
Cambridge 165
Shanghai 164
Lauterbourg 152
Buffalo 135
Jakarta 135
Vienna 131
São Paulo 103
Lachine 102
Guangzhou 101
Orem 100
Moscow 98
Helsinki 93
Altamura 92
Dong Ket 89
Lawrence 82
Munich 78
Da Nang 77
Nanchang 72
Haiphong 71
Tokyo 70
Shenyang 64
London 58
Nuremberg 56
Baghdad 54
Warsaw 52
Andover 51
Chennai 50
Rome 50
Brooklyn 49
Phoenix 49
Ha Long 48
Hải Dương 47
Changsha 46
Denver 45
Rio de Janeiro 45
Biên Hòa 44
Montreal 43
Vilnius 42
Zurich 42
Amsterdam 41
Atlanta 41
Jinan 41
Zhengzhou 41
Carate Brianza 40
Tianjin 40
Jiaxing 38
Stockholm 38
Grafing 37
Johannesburg 37
San Diego 36
Bắc Ninh 35
Columbus 35
Ottawa 35
San Francisco 35
Fremont 34
Ninh Bình 34
Tashkent 34
Can Tho 33
Mexico City 33
Pune 33
Quận Bình Thạnh 32
Hebei 31
Manchester 31
Poplar 30
Brussels 29
Basingstoke 28
Falls Church 28
Totale 26.757
Nome #
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 578
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 509
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 497
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 496
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 446
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 444
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 432
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 429
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 426
Age-related changes in the function and structure of the peripheral sensory pathway in mice 422
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 420
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 413
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 406
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 390
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 386
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 384
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 381
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 373
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 361
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 359
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 353
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 349
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 348
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 346
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 336
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 331
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 324
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 318
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 312
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 307
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 307
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 306
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 304
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 301
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 301
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 301
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 298
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 297
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 296
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 294
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 290
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 290
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 288
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 284
In vivo study of Carfilzomib-Induced Neuropathy 281
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 280
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 279
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 274
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 271
Effect of proteasome inhibition on the central and peripheral nervous system 270
Multimodal experimental approach to the study of human neurological diseases 268
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 265
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 265
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 264
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 261
MSCs effect on Dark Agouti rats affected by chronic EAE 258
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 256
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 253
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 252
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 252
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 250
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 250
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 249
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 249
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 248
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 248
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 248
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 248
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 247
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 245
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 245
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 244
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 244
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 244
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 243
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 242
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 242
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 242
Lipoplatin tm: a less neurotoxic formulation of cisplatin 240
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 240
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 236
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 235
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 235
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 233
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 233
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 230
NOVEL HIGH-RESOLUTION-APPROACHES TO STUDY THE VASCULAR NETWORKS IN THE PERIPHERAL NERVOUS SYSTEM OF RATS WITH CISPLATIN-INDUCED PERIPHERAL NEUROTOXICITY 229
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 229
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 229
Focus on the role of Glutamate in the pathology of the peripheral nervous system 225
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 225
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 224
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 224
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 223
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 221
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 221
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 219
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 216
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 215
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 214
Totale 29.706
Categoria #
all - tutte 130.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.859


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021292 0 0 0 0 0 0 0 0 0 0 0 292
2021/20221.700 102 165 121 158 144 195 68 91 70 127 113 346
2022/20233.151 383 826 330 271 203 507 56 162 275 34 64 40
2023/20242.645 95 76 100 112 326 657 458 128 170 67 49 407
2024/20256.915 394 844 609 318 543 275 443 222 785 856 562 1.064
2025/202618.125 2.397 1.566 1.993 1.514 1.652 1.021 2.486 967 1.452 1.528 1.185 364
Totale 43.302